Privacy Policy
Cookie Policy
Latest Interview
Tim Ferris basically said he wants to be Sol Orwell. Sol was living the 4 hour work week before you read the book. Before you heard of the book. Hear how he does it. Hear how you can do it, too! Every startup and entrepreneur who seeks more flexibility, more efficiency, and more success will benefit from today’s show!
DomainSherpa December 10, 2018 5
More Interviews
According to Consumer Reports, “of the more than 54,000 dietary supplement products in the Natural Medicines Comprehensive Database, only about a third have some level of safety and effectiveness that is supported by scientific evidence. And close to 12 percent have been linked to safety concerns or problems with product quality.” Learn why Sol Orwell, the founder of Examine.com, came out of retirement to educate people about the waste and issues associated with the $10+ billion dietary supplements industry; how he partnered for success; why he chose the brandable domain name Examine.com over exact-match domain names like Supplements.com; how he iteratively grew the business while updating their business model; and much more. If you are or thinking about developing a Internet-based business, this is a must-watch interview.
Michael Cyger December 16, 2013 6 Signup for the DomainSherpa Newsletter
Sol Orwell Archive
Sherpa Founders Series: Pump Up on Entrepreneurship Tips – with Sol Orwell
How Examine.com Is Collating Scientific Research for Public Consumption – With Sol Orwell
Do not register TM domains. Use sound judgement.PAST INTERVIEWS
Past Portfolio Reviews
Profitable Flips
Trader: Interestingly the whois showed that LunchPit.com had two other us...
Derrick: In addition to my last comment, I did some further digging. I wen...
Derrick: No. Godaddy does do this. I looked up a name and it was available...
Jen: Thank-you very much for sharing your feedback and insights, Kathl...
Kathleen Kalaf: Domain Sherpa, I watched your March 23 podcast, and want to than...
About | Advertising | Affiliate Links | Disclaimer | Disclosures | Privacy | Terms | Contact Us
Privacy Overview